
Join to view full profile
450 Brookline AveBoston, MA 02215
Phone+1 617-632-4244
Fax+1 617-632-4897
Dr. Wright is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2006 - 2010
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Pediatrics, 2003 - 2006
Lewis Katz School of Medicine at Temple UniversityClass of 2003
Certifications & Licensure
TN State Medical License 2006 - 2028
MA State Medical License 2016 - 2027
VT State Medical License 2003 - 2006
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma Start of enrollment: 2018 Aug 01
Publications & Presentations
PubMed
- An Emerging Pediatric CNS Tumor: Imaging Evaluation ofandComutated Midline Tumors.Vanessa Rameh, Loai Aker, Sridhar Vajapeyam, Alireza Ziaei, Kee Kiat Yeo
AJNR. American Journal of Neuroradiology. 2026-03-04 - Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas.April A Apfelbaum, Eric Morin, Dominik Sturm, Georges Ayoub, Jeromy DiGiacomo
Nature Communications. 2025-10-09 - and-Altered gliomas and glioneuronal tumors-clinico-pathologic and radiologic perspective in a cohort treated with targeted therapy.Carolyn G Chen, Vanessa Rameh, Tom Rosenberg, Kee Kiat Yeo, Susan Chi
Neuro-Oncology Advances. 2025-09-08
Press Mentions
First-of-Their-Kind Findings Turn Conventional Wisdom About Diffuse Hemispheric Glioma on Its HeadOctober 22nd, 2024
Adolescent Glioma Subtype Responds to CDK4/6 InhibitorSeptember 3rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: